Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   CEPS(Rs) 48.1717.1330.6530.6539.64

What is the latest Cash Earnings per Share (CEPS) ratio of NATCO PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of NATCO PHARMA is 48.17 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202348.17
Mar202217.13
Mar202130.65
Mar202030.65
Mar201939.64

How is Cash Earnings per Share (CEPS) of NATCO PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 48.17
181.20
Mar2022 17.13
-44.11
Mar2021 30.65
0.00
Mar2020 30.65
-22.68
Mar2019 39.64 -

Other Financial Ratios of NATCO PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,822.2 Cr 1% 0.5% 59.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

0.5%

59.4%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses